Numerous studies reported that individual molecular components of the circadian clock, such as BMAL1 [38,89,90,91,92,93], PER2 [94,95,96], or PER1 [47] suppress proliferation or increase the sensitivity to anti-cancer drugs in different cancer cell lines. This evidence concerns the gene PER1 and cancer.